Compare HYLN & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HYLN | TNDM |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2019 | 2013 |
| Metric | HYLN | TNDM |
|---|---|---|
| Price | $4.06 | $15.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 19 |
| Target Price | $5.00 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 5.5M | 2.1M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,475,000.00 | ★ $1,014,736,000.00 |
| Revenue This Year | $197.93 | $8.11 |
| Revenue Next Year | $301.97 | $11.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 130.28 | 7.93 |
| 52 Week Low | $1.40 | $10.00 |
| 52 Week High | $8.49 | $29.65 |
| Indicator | HYLN | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 37.59 | 43.84 |
| Support Level | $1.79 | $13.59 |
| Resistance Level | $8.49 | $16.00 |
| Average True Range (ATR) | 0.68 | 0.90 |
| MACD | -0.35 | 0.01 |
| Stochastic Oscillator | 2.20 | 37.50 |
Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.